Is there a choice of palliation for tetralogy of fallot?  by Sommer, Robert J. & Golinko, Richard J.
166 
Editorial Comment 
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The surgical management of symptomatic infants with tetral-
ogy of Fallot remains controversial. Several centers (1-4) 
have achieved acceptably low mortality and morbidity rates 
using primary correction at the time of diagnosis. However, 
the unknown long-term consequences of early right ventric-
ulotomy and trans annular patch placement leave the issue of 
optimal therapy largely unresolved. Most centers continue 
to provide palliative treatment for these infants with some 
type of aortopulmonary shunt and perform definitive correc-
tive surgery in older children. In this issue of the Journal, 
Sreeram et al. (5) present their results with balloon pulmo-
nary valvuloplasty performed as an alternative palliative 
procedure to aortopulmonary shunting in 67 infants with 
tetralogy of Fallot. 
Indications for surgery. Infants with tetralogy of Fallot 
may manifest symptoms in two ways. First, they may have 
cyanosis at rest because of right to left shunting at the 
ventricular septal defect. This is of concern because chronic 
hypoxemia appears to be related to lower intelligence (6) and 
results in polycythemia with its attendant risks (7). The most 
urgent danger to these patients, however, is the classic 
cyanotic "spell" of tetralogy of Fallot. Infundibular spasm 
and sudden increase in right ventricular outflow obstruction 
contribute to decreased pulmonary blood flow (8). A marked 
fall in systemic oxygen content follows, with a risk of 
syncope, seizures and sudden death. This is a life-
threatening emergency and in most centers is considered an 
indication for immediate surgical intervention. 
The classic palliative procedure for these patients has 
been the Blalock-Taussig shunt (subclavian artery to pulmo-
nary artery anastomosis). Systemic to pulmonary artery 
flow, across the shunt, results in a higher level of oxygen 
saturation at rest through the augmentation of anterograde 
pulmonary blood flow. More important, in the presence of an 
alternate source of pulmonary blood flow, acute infundibular 
obstruction is no longer a life-threatening event. 
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Role of balloon valvuloplasty. Because valvular stenosis 
contributes significantly to the degree of right ventricular 
outflow tract obstruction in the patient with tetralogy of 
Fallot, balloon valvuloplasty may increase pulmonary blood 
flow and systemic oxygen saturation at rest. Balloon pulmo-
nary valvuloplasty has been proved a safe and efficacious 
procedure for the treatment of isolated valvular pulmonary 
stenosis in infants and children (9). However, the obstruc-
tion to pulmonary flow in tetralogy of Fallot is complex and 
may include subvalvular (infundibular), valvular, supraval-
vular and often peripheral stenotic components. Although 
balloon angioplasty may also provide palliative treatment for 
supravalvular and peripheral lesions (10), it has no direct 
impact on the degree of infundibular stenosis. The latter is 
due anatomically to the anterior malalignment of the inter-
ventricular septum. 
Therefore, the underlying premise of balloon valvulo-
plasty for tetralogy of Fallot must be questioned. The risk of 
"spells" remains real, regardless of the systemic oxygen 
saturation at rest, as a result of potential subvalvular com-
promise of pulmonary blood flow. 
The present study. The 67 patients of Sreeram et al. (5) 
were grouped retrospectively by outcome. In two patients 
the anulus could not be crossed with the catheter and 
aortopulmonary shunting was performed; 65 patients under-
went balloon dilation. The investigators (5) did not mention 
the occurrence of cyanotic spells during the catheterization 
procedure, a frequent complication of angiographic studies 
of patients with tetralogy of Fallot. Of the 35 patients who 
were restudied angiographically at a later date, 11 (group B) 
had undergone aortopulmonary shunting secondary to "in-
adequate palliation." Sreeram et al. (5) did not discuss the 
clinical indications for surgical intervention. Did these chil-
dren have life-threatening cyanotic spells? The other 24 
patients (group A) were considered to have "adequate 
palliation." However, in 10 of these patients medical ther-
apy with propranolol had been initiated because of recurrent 
cyanotic spells that were presumably not severe enough to 
warrant surgical intervention. Of the 30 patients who were 
not yet restudied (group C), 3 were being treated medically 
for cyanotic episodes, 7 had received a surgical shunt and 5 
died during the follow-up period. The cause of death in three 
of these five was not mentioned. 
With beta-adrenergic blocking therapy, the frequency and 
severity of cyanotic episodes are lessened but not elimi-
nated. Therefore, the patients on medical therapy must also 
be considered to have had an unsuccessful palliative proce-
dure. When the patients who required beta-blocker therapy 
are grouped with those who underwent surgical palliation, 
the failure rate among the 67 patients is 57%. More signifi-
cant, the authors (5) were unable to distinguish prospectively 
the patients who would require subsequent surgical pallia-
tion or beta-blocker therapy. Thus, there was no way to be 
certain that a given child would be adequately protected 
from the potential complications of a cyanotic spell. 
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Implications. The growth of the pulmonary anulus in this 
series of patients (5) should be noted. Adequate annular 
growth would be of great benefit because it might obviate the 
need for a transannular patch at a later surgical correction. 
From this perspective, perhaps balloon valvuloplasty could 
be incorporated as part of an overall palliative schema after 
an aortopulmonary shunt. Valvuloplasty itself would cer-
tainly be safer in the patient after a shunt and would avoid 
the danger of "spells" in the catheterization laboratory. 
Although some patients treated in this manner would de-
velop congestive heart failure secondary to excessive pul-
monary blood flow and some would develop significant 
pulmonary insufficiency, the potential benefit of avoiding a 
transannular patch might outweigh both of these risks. 
Conclusions. The work by Sreeram et al. (5) is an inter-
esting new application of an established palliative technique. 
However, balloon pulmonary valvuloplasty in patients with 
tetralogy of Fallot provides inadequate control of pulmonary 
blood flow. These patients remain at risk for cyanotic spells 
with the possibility of neurologic injury or sudden death, or 
both. Valvuloplasty should not be considered an alternative 
to surgical palliation. 
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